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ABSTRACT. Inflammatory diseases of the central nervous system are common causes of neurological dysfunction in the dog 
and can be grouped into two broad categories; those of infectious and those of unknown aetiology. Μeningoencephalomyelitis 
of unknown aetiology include non-infectious inflammatory central nervous system diseases in which abnormal findings on mag-
netic resonance imaging and cerebrospinal fluid analysis indicate inflammatory central nervous system disease, but for which 
histopathological confirmation has not been reached. Meningoencephalomyelitis of unknown aetiology describes a group of 
non-infectious inflammatory diseases of the central nervous system. These include the granulomatous meningoencephalomyelitis 
and the necrotising encephalitis, the latter can be further distinguished into two subtypes: necrotising meningoencephalitis and 
necrotising leucoencephalitis. Steroid-responsive meningitis-arteritis may be also included to this category and, usually, does not 
present signs of encephalitis or/and myelitis (except in the chronic form) and is easier diagnosed even without histopathological 
examination. In most cases of meningoencephalomyelitis of unknown aetiology, a presumptive diagnosis can be achieved by the 
assessment of case presentation, the neurologic signs, cerebrospinal fluid testing, cross-sectional imaging of the central nervous 
system and appropriate microbiological tests. Definite diagnosis is achieved with histopathological examination. The underlying 
cause for these diseases is unknown. The clinical signs in meningoencephalomyelitis of unknown aetiology is variable and depends 
on which area of the central nervous sytem is affected. Meningoencephalomyelitis is acute in onset, progressive in nature and asso-
ciated with multifocal to diffuse neuroanatomic localization. Extraneural signs are less common and these usually include pyrexia 
and peripheral neutrophilia. The differential diagnosis for dogs presented for an acute onset of multifocal central nervous system 
signs includes genetic abnormalities, metabolic disorders, infectious meningoencephalitis, toxin exposure, stroke and neoplasia. 
The diagnostic approach includes a complete blood count, a comprehensive chemistry panel, urinalysis, survey radiographs of the 
thorax plus abdominal ultrasound to rule out systematic disease and metastatic neoplasia, computed-tomography or magnetic reso-
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arteritis may be also included to this category. 
Meningoencephalomyelitis of unknown aetiology 
usually have acute onset and rapid deterioration of 
the clinical signs, although, sometimes, they are 
present with a long-standing clinical course (Le 
Couteur, 2009).
The underlying causes of meningoencephalomy-
elitis of unknown aetiology are unknown. Proposed 
causes include infectious (Schatzberg et al., 2005), 
auto-immune (Kipar et al., 1998, Matsuki et al., 
2009) and neoplastic conditions. Moreover, for some 
breeds, there may be a genetic component for these 
disorders (Greer et al., 2008). Numerous attempts 
have been made to identify infectious agents in 
affected dogs, but, up to date, these have been unsuc-
cessful. a possible explanation is that these disease 
processes may be triggered by an infectious agent 
INTRODUCTION
Inflammatory diseases of the central nervous system are common causes of neurological 
dysfunction in the dog and can be grouped into two broad 
categories; those of infectious and those of unknown 
aetiology. Μeningoencephalomyelitis of unknown 
aetiology include non-infectious inflammatory central 
nervous system diseases in which abnormal findings 
on magnetic resonance imaging and cerebrospinal fluid 
analysis indicate inflammatory disease, but for which 
histopathological confirmation has not been reached.
Meningoencephalomyelitis of unknown aetiol-
ogy includes the granulomatous meningoencepha-
lomyelitis and the necrotising encephalitis, the lat-
ter can be further distinguished into two subtypes: 
necrotising meningoencephalitis and necrotising 
leucoencephalitis. Steroid-responsive meningitis-
nance imaging, cerebrospinal fluid analysis and microbiological tests. When neoplasia is suspected, computed-tomography-guided 
brain biopsy may be required for the differentiation. Meningoencephalomyelitis of unknown aetiology responds more or less to 
immunosuppressive therapies, but the prognosis should be guarded to poor with the exception of steroid-responsive meningitis-
arteritis, for which it is good. Treatment protocols are based on prednisolone, but new immunosuppressive agents have now been 
added in those to control the diseases and they seem to be effective. However, gold standard protocols have yet to be established.
Keywords: dog, inflammatory diseases, meningoecephalomyelitis, nervous system
ΠΕΡΙΛΗΨΗ. Στη μηνιγγοεγκεφαλομυελίτιδα άγνωστης αιτιολογίας περιλαμβάνονται η κοκκιωματώδης μηνιγγοεγκεφαλίτιδα, 
η νεκρωτική μηνιγγοεγκεφαλίτιδα και η νεκρωτική λευκοεγκεφαλίτιδα. Καθεμία από τις παραπάνω, μη μικροβιακής αιτιολογίας 
εγκεφαλοπάθειες έχει διαφορετικά ιστοπαθολογικά ευρήματα. Περαιτέρω, στις εν λόγω νόσους περιλαμβάνεται και η μηνιγγίτι-
δα-αρτηρίτιδα που ανταποκρίνεται στα γλυκοκορτικοστεροειδή, η οποία όμως συνήθως περιγράφεται χωριστά, επειδή εκδηλώ-
νεται σπάνια με συμπτώματα εγκεφαλίτιδας και/ή μυελίτιδας (εκτός από τη χρόνια μορφή αυτής). Η κλινική διάγνωσή τους μπο-
ρεί να γίνει με βάση το ιστορικό, την κλινική εικόνα, τα ευρήματα της ανάλυσης του εγκεφαλονωτιαίου υγρού, τις ειδικές ανο-
σολογικές εξετάσεις στο αίμα και το εγκεφαλονωτιαίο υγρό και τα ευρήματα των απεικονιστικών εξετάσεων. Μολαταύτα, για 
οριστική διάγνωση απαιτείται ιστοπαθολογική εξέταση. Η ακριβής αιτιολογία των εν λόγω παθολογικών καταστάσεων παραμέ-
νει άγνωστη, πολύ πιθανόν όμως αυτές να είναι ανοσολογικής φύσεως. Η κλινική εικόνα της μηνιγγοεγκεφαλομυελίτιδας άγνω-
στης αιτιολογίας ποικίλει, εξαρτώμενη από την έκταση της προσβολής του κεντρικού νευρικού συστήματος. Τα συμπτώματα, 
που εκδηλώνονται απότομα και εξελίσσονται προοδευτικά, συνήθως υποδηλώνουν διάχυτη ή πολυεστιακή εγκεφαλοπάθεια. Στα 
γενικά συμπτώματα, τα οποία εν γένει δεν παρατηρούνται συχνά, περιλαμβάνονται ο πυρετός και η λευκοκυττάρωση. Η δια-
φορική διάγνωση περιλαμβάνει τα κληρονομικά, τα μεταβολικά και τα λοιμώδη νοσήματα, τις νευροτοξικώσεις, την ισχαιμική 
εγκεφαλοπάθεια και τις νεοπλασίες του εγκεφάλου. Η αιτιολογική διάγνωση είναι δύσκολη. Η αρχική εργαστηριακή διερεύνηση 
αποσκοπεί στον αποκλεισμό των συστηματικών παθήσεων με τη διενέργεια εργαστηριακών (πλήρης αιματολογική και βιοχημι-
κή εξέταση του ορού του αίματος, ανάλυση ούρου) και απεικονιστικών (ακτινογραφίες θώρακα και υπερηχογράφημα κοιλίας) 
εξετάσεων. Η διάγνωση της μηνιγγοεγκεφαλομυελίτιδας άγνωστης αιτιολογίας στηρίζεται στις ειδικές απεικονιστικές εξετάσεις 
(αξονική και μαγνητική τομογραφία) και στην ανάλυση του εγκεφαλονωτιαίου υγρού. Σε κάποια περιστατικά, μπορεί να γίνει 
βιοψία από τις αλλοιώσεις με τη βοήθεια ειδικής βελόνης βιοψίας υπό καθοδήγηση αξονικού ή μαγνητικού τομογράφου. Στο 
αρχικό στάδιο της νόσου, υπάρχει ανταπόκριση στην αγωγή με ανοσοκατασταλτικά φάρμακα, όμως μέχρι σήμερα δεν έχει 
βρεθεί κάποιο αποτελεσματικό θεραπευτικό σχήμα. Η πρόγνωση είναι συνήθως επιφυλακτική ή και κακή. Εξαίρεση αποτελεί η 
μηνιγγίτιδα-αρτηρίτιδα που ανταποκρίνεται στα γλυκοκορτικοστεροειδή, της οποίας η πρόγνωση είναι καλή.
Λέξεις ευρετηρίασης: μηνιγκοεγκεφαλίτιδα, νευρικό σύστημα, σκύλος, φλεγμονώδης νόσος
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that is rapidly eliminated, but which, nevertheless, 
has initiated a destructive immune response. as 
a result, treatment protocols applied are based, in 
principle, on immunosuppressing the animal (Olby, 
2010).
GRANULOMATOUS 
MENINGOENCEPHALOMYELITIS
Granulomatous meningoencephalomyelitis is 
an inflammatory disease of the central nervous sys-
tem, which affects mainly dogs and, rarely, cats 
(Vandevelde et al., 1981; Braund, 1985; Robin et al., 
1993). The disorder may account for up to 25% of 
all central nervous system diseases in dogs (Tipold, 
1995). The cause of granulomatous meningoen-
cephalomyelitis is unknown. although it has been 
suggested that a T cell-mediated delayed-type hyper-
sensitivity can be a possible pathogenetic mechanism 
for the disease (Kipar et al., 1998). This mecha-
nism would lead to formation of peri-vascular cel-
lular infiltrates of histiocytic cells mixed with lym-
phocytes, plasma cells and, occasionally other leu-
kocytes, involving the majority of the blood vessels 
in the white matter (predominantly), as well as the 
pia matter of the central nervous system (Cordy, 
1979). It is also possible that granulomatous menin-
goencephalomyelitis represents an altered host 
response to an infectious agent or a genetic disorder 
(Sutton and atwell, 1982). It has been also reported 
that the disease may be triggered by vaccination 
against canine distemper and rabies (Harris et al., 
1988), which lends support to the hypothesis of auto-
immune type disease.
Clinical presentation
Most cases of granulomatous meningoencephalo-
myelitis occur in small breed dogs, more commonly 
in terrier and toy breeds and in Poodles, although any 
breed may be affected (Munana, 1996). Most cases 
of the disease would occur in young- to middle-aged 
dogs, mean age of animals with the disorder being 
~5 years (range: 6 months-12 years). Granulomatous 
meningoencephalomyelitis occurs in animals of both 
sexes; however, there appears to be a higher inci-
dence risk for the disease in female dogs (Munana 
and Luttgen, 1998).
Clinical signs
Granulomatous meningoencephalomyelitis 
occurs as an acute-onset, progressive, multifocal 
neurologic disease that may be fatal if left untreated 
(Munana et al., 1998; De Lahunta and Glass 2009). 
Clinically, the disease is characterised by three clini-
cal differing presentations: multifocal, focal, ocular.
The multifocal form is the most common; typi-
cally, it has acute onset, with rapidly progressing 
multifocal neurologic signs over a period of one 
to eight  weeks, involving the cerebrum, the cau-
dal brainstem, the cerebellum or the cervical spinal 
cord (Cordy, 1979; Braund, 1985; Munana, 1996). 
Clinical signs, which reflect a multifocal syndrome, 
as a result of the scattered distribution of the lesions, 
include incoordination, vestibular or proprioceptive 
ataxia, cervical hyperesthesia, head tilt, nystagmus, 
facial and/or trigeminal nerve paralysis, circling, 
visual deficits, seizures and depression (Braund et al., 
1978; alley et al., 1983; Bateman and Parent, 1999). 
Occasionally, fever and peripheral neutrophilia 
would accompany the neurological signs (Cordy, 
1979; Sorjonen, 1990).
The focal form of the disease is less common, 
although focal signs have been reported in up to 50% 
of cases (Munana and Luttgen, 1998). This form rep-
resents a true mass lesion located most often in the 
cerebral hemispheres, brainstem or spinal cord (De 
Lahunta and Glass, 2009).
an infrequently reported ocular form of granu-
lomatous meningoencephalomyelitis appears to be 
related to lesions localized in the optic nerves and 
optic chiasm and can result in visual impairment 
and abnormal pupillary reflexes. a hyperaemic and 
oedematous optic disk may be seen in ophthalmic 
examination; vessels can be seen to be dilated, whilst 
focal haemorrhage may be present. Dogs with the 
ocular form of the diseases may also, concurrently, 
show or develop the multifocal form (Braund, 1985; 
De Lahunta a and Glass, 1995).
Generally, it has been reported that 50% of the 
dogs with granulomatous meningoencephalomy-
elitis have forebrain-type symptoms and 50% have 
both forebrain-type and brainstem-type symptoms. 
In addition, dogs with acute form of the disease 
show often signs of central vestibular syndrome (Le 
Couteur, 2009). Cervical spinal pain is also common 
in patients with more often and it can sometimes pre-
exist in combination with spinal cord signs.
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Diagnosis
a tentative diagnosis may be suggested by the 
medical history, the clinical presentation, the results 
of clinical examination, the examination of cerebros-
pinal fluid and the findings from neuroimaging (mag-
netic resonance imaging, computed-tomography). 
Definitive diagnosis is based on the histopathological 
findings in lesional central nervous system tissue, 
which can be collected by computed-tomography-
guided brain biopsy or other neurosurgical tech-
niques (craniotomy or laminectomy) (Le Couteur, 
2009).
In most dogs, results of examination of cerebro-
spinal fluid indicate mild to pronounced pleocytosis, 
ranging from 50 to 900 leucocytes μL-1. Mononuclear 
cells, mainly lymphocytes (60%-90%) and mono-
cytes (10%-20%) can also be present (Fig. 1). While 
neutrophils typically comprise from 1%-20% of 
leucocytes the cerebrospinal fluid, they may be the 
predominant cell type on rare occasions. Protein con-
centration is usually mildly or moderately increased, 
ranging from 40 to 400 mg dL-1 (Russo, 1979; 
Demierre et al., 2001).
The most common magnetic resonance imag-
ing findings for the multifocal form include multiple 
hyperintensities on T2-weighted or fluid-attenuated 
inversion recovery (FLaIR) sequences scattered 
throughout the central nevous system white matter. 
These lesions typically assume an infiltrative appear-
ance and have irregular margins. Lesions visible in 
magnetic resonance imaging often are distributed 
throughout both gray and white matter. The lesions 
display a variable intensity on T1-weighted images 
and variable degrees of contrast enhancement (Fig. 
2). Meningeal enhancement is uncommon (Cherubini 
et al., 2006). The focal form may be indentified on 
magnetic resonance imaging or computed-tomogra-
phy as a non-specific single space-occupying mass 
lesion (Speciale et al., 1992). In the optic form, optic 
nerves may be iso-intense on T2-weighted images 
and may enhance on T1-weighted image with con-
trast medium; the optic chiasm also may appear 
enlarged (Kitagawa et al.; 2009).
Computed-tomography may reveal evidence of 
brain inflammation, although it is not as sensitive as 
magnetic resonance imaging in delineating the paren-
chymal and meningeal lesions. Both focal and multi-
focal forms may be associated with contrast enhance-
ment on computed-tomography and a mass effect 
may be observed by displacement of the surrounding 
brain tissue. The multifocal form is characterized 
by presence of multiple poorly defined, enhancing 
lesions of the parenchyma and meninges (Plummer 
et al., 1992).
Differential diagnosis
The differential diagnosis includes infectious 
meningoencephalomyelitis (including canine distem-
per encephalomyelitis, toxoplasmosis, neosporosis 
and cryptococcosis) and brain tumours.
Differentiation from canine distemper encepha-
lomyelitis can be based on vaccination history and 
the presence of systemic (respiratory, gastrointes-
tinal) signs, although sometimes vaccinated dogs 
may also be affected (Braund, 1980). Differentiation 
from toxoplasmosis and neosporosis can be based on 
information from history, clinical presentation, clini-
cal pathology findings (non-regenerative anaemia, 
increase of blood neutrophils concentration, lym-
phocytosis, eosinophilia and increased serum alanine 
transaminase, aspartate aminotransferase, kreatinine 
cinase activity, especially in dogs with acute liver 
and/or muscle necrosis) (Dubey and Lappin, 1998) 
and measurement of serum IgG and IgM; IgM indi-
cate active infection by the above protozoa, hence its 
measurement is preferable to that of IgG (Bjorkman 
and Uggla, 1999). PCR could also aid as it detects 
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Fig. 1. Predominance of lymphocytes in cerebrospinal fluid sample 
from a dog with granulomatous meningoencephalomyelitis (modi-
fied Wright-Giemsa, ×60 objective).
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Prognosis
Prognosis of granulomatous meningoencepha-
lomyelitis is poor without aggressive immunosup-
pression. Immunosuppressive treatment, mainly cor-
ticosteroids, is believed to markedly improve the 
clinical outcome (Coates et al., 2007). Most of the 
affected dogs succumb to the disorder or are eutha-
nised within a few weeks to months after diagnosis, 
despite the treatment. Dogs with granulomatous 
meningoencephalomyelitis have been reported to 
survive longer (3-6 months or even more) than those 
with the multifocal form, which die within a few 
days to weeks (median interval from diagnosis to 
death: 8 days). Dogs with focal forebrain-type signs 
had significantly longer survival times (>1 year) than 
dogs with signs indicating localisation in other areas 
of the central nervous system (2 months) (Munana 
and Luttgen, 1998).
protozoal DNa and is highly sensitive (Spencer et 
al., 2000). Cryptococcosis is rare and, apart from 
the neurological signs, it is accompanied with other 
symptoms, e.g., nasal and ocular discharge and sub-
mandibular lymph node enlargement. Moreover, as 
in toxoplasmosis/neosporosis, serological testing and 
PCR will aid in the diagnosis. In addition to this, the 
demonstration of organisms on smears taken from 
the discharge and in cultures from it will differenti-
ate between the two diseases (Berthelin et al., 1994). 
Finally, brain tumours can be differentiated from 
granulomatous meningoencephalomyelitis mainly by 
the magnetic resonance imaging findings, although 
this may prove difficult in some cases. as a result, 
histologic examination of the lesions may be inevi-
table.
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Fig. 2. Magnetic resonance imaging findings in multifocal granulomatous meningoencephalomyelitis: (a) sagittal, T2-weighted MR image 
at the level of midline, with focal hyper-intense area in the brainstem extending from pons cranially to medulla oblongata caudally; (b) 
transverse, fluid-attenuated inversion recovery MR image at the level of the pons, with hyper-intensity of previously described brainstem 
lesion and hyper-intense lesion in the caudal right occipital lobe, reflecting focal inflammation and oedema; (c) transverse T1W pre-con-
trast MR image at the same level as (b), with extremely mild hyper-intensity of the right occipital lobe lesion involving the grey and white 
matter, whilst the brainstem lesion is iso-intense to the surrounding tissue and cannot be visualized; (d) transverse T1W post-contrast MR 
image at the same level as (b), with the occipital lobe lesion enhancing and the brainstem lesion not enhancing (figure generously provided 
by Dr Nicolas Rousset from the Queen’s Veterinary School Hospital of the University of Cambridge).
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NECROTISING ENCEPHALITIS
There are two distinct subtypes of necrotising 
encephalitis: necrotising meningoencephalitis and 
necrotizing leucoencephalitis. Both have similar 
clinical presentation and histopathologic features, as 
they cause bilateral, asymmetric cerebral necrosis. 
Necrotising meningoencephalitis commonly affects 
the cerebral hemispheres and subcortical white mat-
ter, with profound inflammation extending from the 
leptomeninges through the cerebral cortex into the 
corona radiata (De Lahunta and Glass, 1995). On the 
other hand, necrotising leucoencephalitis is relatively 
sparing of the cerebral cortex and meninges, predom-
inately affecting perivascular cerebral white matter, 
including the centrum semiovale, the thalamocortical 
fibres, the internal capsule, the thalamus and, some-
times, the brainstem (Le Couteur, 2009).
The aetiopathogenesis for these disorders is not 
yet fully understood. It is believed that a combination 
of genetic, infectious (mainly Canine Herpesvirus-1) 
and environmental factors trigger the onset of necro-
tising encephalitis through the immune mediated 
responses (Percy et al., 1970; Whitley and Gnann, 
2002). as far as necrotising meningoencephalitis is 
concerned, it has been suggested that auto-antibodies 
against astrocytes and glial cells (anti-astrocytic 
and glial fibrillary acid protein antibodies) may be 
responsible for the disease, based on their presence 
in the cerebrospinal fluid of affected dogs. However, 
similar antibody levels occur in the cerebrospinal 
fluid of dogs with granulomatous meningoencepha-
lomyelitis or brain tumours, even in a few clinically 
normal dogs (Shibuya et al., 2007).
Clinical presentation
Necrotising encephalitis is breed-specific. 
Breeds affected include Pugs, Maltese, Chihuahuas, 
Yorkshire Terriers, Pekingese, West Highland White 
Terriers, Boston terriers, Japanese Spitz, Miniature 
Pinschers, French Bulldogs, Lhasa apso and Shih-
Tzu (Cordy et al., 1989; Coates, 2011). Necrotising 
meningoencephalitis affects more often Pugs and 
Maltese and necrotising leucoencephalitis Yorkshire 
Terriers and French Bulldogs (Coates, 2011).
Most cases of necrotising meningoencephalitis 
occur in young dogs. age of dogs at onset of clini-
cal signs range from 6 months to 7 years, with mean 
age being 2.5 years (Cordy and Holliday, 1989). 
Necrotising leucoencephalitis occurs in animals aged 
4 months to 10 years, with the mean age being 4.5 
years (Kuwamura et al., 2002). Female animals are 
more frequently affected than males (Coates, 2011).
Clinical signs
Dogs with necrotising encephalitis commonly 
manifest cerebrothalamic-type signs, because of the 
localisation of the lesions in the prosencephalon. In 
necrotising leucoencephalitis, mid-to-caudal brain-
stem-type signs may also occur, due to additional 
lesions in that area of the brain. The clinical signs 
progress rapidly; most commonly, they include sei-
zures, depression, circling, vestibulocerebellar-type 
signs, visual deficits, ultimately leading to death 
(Coates, 2011). Generally, the signs vary and depend 
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Fig. 3. Magnetic resonance imaging findings in necrotising en-
cephalopathy: (a) transverse, T1-weighted MR image at the level 
of thalamus and cerebral hemispheres, with hypo-intense lesion 
involving the grey/white matter peripherally in the right parietal 
lobe and a further hypo-intense lesion identified in the right tha-
lamus with a mass effect and midline shift towards the left; (b) 
transverse, T2-weighted MR image at the same level as (a), with 
hyper-intensity of the previously (a) described lesions; (c) right 
parasagittal, T2-weighted MR image, with focal hyper-intensity 
of the right thalamus (figure generously provided by Dr Nicolas 
Rousset from the Queen’s Veterinary School Hospital of the Uni-
versity of Cambridge).
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on the brain area that has been affected (De Lahunta 
and Glass, 2009). Cervical spinal pain is a common 
symptom that occurs, because of the localization 
of the lesions in the meninges and/or the forebrain 
(Munana, 1996).
Diagnosis
a tentative diagnosis of the NE may be sug-
gested by the history, the clinical presentation, the 
results of clinical examination, the results of cerebro-
spinal fluid analysis and the neuroimaging findings 
(magnetic resonance imaging, computed-tomogra-
phy). Definitive diagnosis is based on the histologi-
cal examination of the lesions. Cerebrospinal fluid 
analysis, as in granulomatous meningoencephalomy-
elitis, reveals increased protein content and mono-
nuclear (usually lymphocytic) pleocytosis. Magnetic 
resonance imaging lesions associated with necr-
otising meningoencephalitis include asymmetric, 
multifocal prosencephalic-type lesions affecting the 
gray and white matter that appear hyper-intense on 
T2-weighted images and iso-intense to slightly hypo-
intense on T1-weighted images, with slight contrast 
enhancement. Loss of gray/white matter demarcation 
may be noticed (Fig. 3). In necrotising leucoencepha-
litis, multiple, asymmetric bilateral prosencephalic 
lesions appear mainly in the subcortical white mat-
ter. The lesions are hyper-intense on T2-weighted 
and fluid-attenuated inversion recovery images and 
hypo-intense or iso-intense on T1-weighted images, 
with variable contrast enhancement (von Praun et al., 
2006; Young et al., 2009). Computed-tomography 
scan may also contribute to the diagnosis. In the 
acute, mainly, stages of necrotising encephalitis, 
focal hypodense lesions in the prosencephalon may 
be revealed, which may or may not be enhanced with 
contrast (Thomas, 1998).
Differential Diagnosis
Differential diagnosis includes neoplastic, infec-
tious and immune-mediated disorders of the central 
nervous system.
Prognosis
Prognosis should be guarded and depends on 
severity of clinical signs and distribution of lesions 
in the central nervous system. Median interval from 
diagnosis to death has been estimated to 93 days 
(Coates, 2011).
STEROID-RESPONSIVE MENINGITIS-
ARTERITIS
Steroid-responsive meningitis-arteritis is 
a debilitating inflammatory disease of the canine 
central nervous system. Pathogenesis of the dis-
ease is unclear, but it has been proposed that it may 
be triggered by environmental factors, which acti-
vate an immune-mediated reaction (Tipold et al., 
1995). Specifically, it has been suggested that a 
Th2 immune response is responsible for the disease. 
In that, activated T cells produce large amounts 
of interleukin-4 (IL-4), which stimulates B cells 
to produce large amounts of immunoglobulin a. 
That infiltrates into the meningeal vessels (mainly 
in the cervical area) causing vasculitis and meningi-
tis (Schwartz et al., 2011). Increased concentration 
of immunoglobulin a in blood and cerebrospinal 
fluid (Tipold and Jaggy, 1994; Tipold et al., 1995), 
remission of clinical signs after the administration of 
immunosuppressive doses of steroids (Meric et al., 
1985) and absence of identifiable infectious organ-
isms (Harcourt, 1978; Poncelet and Balligand, 1993; 
Tipold and Jaggy, 1994) lend support to this hypoth-
esis. 
Moreover, it has also been suggested that repeat-
ed vaccinations against various pathogens may cause 
the disease by sensitizing the dog to those antigens. 
This may account for increased incidence of the dis-
ease in young animals (Le Couteur, 2009).
Steroid-responsive meningitis-arteritis may 
sometimes occur in combination with immune-medi-
ated polyarthritis, identified as ‘polyarthritis-menin-
gitis syndrome’.
Clinical presentation
Steroid responsive meningitis-arteritis usually 
affects medium to large breeds of dogs. Specific 
breeds with an increased risk for developing the dis-
ease are the Beagles, the Boxers, the Weimaraners, 
the Bernese Mountain Dogs and the Nova Scotia 
Duck-Tolling Retrievers. The disease occurs mainly 
in dogs younger than 2 years, although it has been 
reported in dogs as old as 7 years (Tipold and Jaggy, 
1994; Coates, 2011).
Webb et al. (2002) described that ~30% of dogs 
with immune-mediated polyarthritis had associated 
spinal pain; subsequently 50% of those were diag-
nosed with steroid responsive meningitis-arteritis. 
Dogs with ‘polyarthritis-meningitis syndrome’ expe-
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rience spinal pain, possibly due to both meningeal 
and intervertebral joint inflammation (Webb et al., 
2002).
Clinical signs
Dogs are presented with cervical spinal hyper-
aesthesia (in over 90% of affected dogs), most com-
monly occurring with low head carriage and arched 
back (Tipold and Jaggy, 1994). Other clinical signs 
that may be present from time to time include reluc-
tance to move, stiff gait, pain on mouth opening, 
muscle rigidity and anorexia. Cervical spinal pain 
may be coupled by thoracolumbar pain, although, 
in some cases, only the latter is present (Le Couteur, 
2009). Pyrexia and neutrophilic leucocytosis with 
a left shift occurs in approximately two-thirds of 
affected dogs (Coates, 2011). Clinical signs may 
have an acute onset and progressive (acute form) or 
with a waxing and waning course over a period of 
weeks or months (chronic form) (Le Couteur, 2009). 
Dogs developing the acute form that remain untreat-
ed may self-limit the clinical signs within 12 to 18 
months (Penderis, 2008) or develop resistance to the 
disease with ageing (Scott-Moncrieff et al., 1992). 
alternatively, they may develop the chronic form, 
where, apart from meningitis, myelitis or encephalitis 
are also present (Tipold and Jaggy, 1994; Wrzosek et 
al., 2009). Therefore, in the chronic form, neurologi-
cal signs (e.g., ataxia, paresis) may occur (Tipold, 
2000). Lastly, it has been reported that inflammation 
may spread from meninges to the cerebral hemi-
spheres, which would potentially be fatal for the ani-
mal (Wrzosek et al., 2009).
Diagnosis
Diagnosis is based on history, clinical presenta-
tion, findings of clinical examination, cerebrospinal 
fluid analysis and supported by haematological and 
biochemical findings. Cerebrospinal fluid analysis 
is characterized by increased total nucleated cell 
count (reference range: <5-8 leucocytes μL-1 for 
cerebellomedullary cistern collection) (Di Terlizzi 
and Platt, 2006; Bathen-Noethen et al., 2008). a 
predominance of neutrophils in the absence of bac-
teria is recorded in animals with acute form of the 
disease (Fig. 4). However, as the disease progresses, 
a mixed pleocytosis is present with macrophages, 
lymphocytes and monocytes (Fig. 5). In association 
with this inflammatory response, an increase in the 
Fig. 4. Smear of cerebrospinal fluid sample from a dog with steroid 
responsive meningitis-arteritis, with predominance of neutrophils, 
of which a large number has with hyper-segmented nuclei, and 
a smaller number of macrophages (modified Wright-Giemsa, (a) 
×20 objective, (b) ×40 objective).
Fig. 5. Smear of cerebrospinal fluid sample from a dog with long-
standing form of steroid responsive meningitis-arteritis, with pre-
dominance of macrophages and scarce macrophages (modified 
Wright-Giemsa, ×60 objective).
138 CHaRaLaMBOUS M., DaNOURDIS T., HaTzIS a., POLIzOPOULOU z.S.
http://epublishing.ekt.gr | e-Publisher: EKT | Downloaded at 21/02/2020 05:58:28 |
J HELLENIC VET MED SOC 2013, 64(2)
ΠΕΚΕ 2013, 64(2)
help localize changes in the central nervous system 
and support monitoring of the efficacy of treatment 
(Tipold, 2000).
Differential diagnosis
Spinal pain may be caused by any condition 
affecting muscles, vertebrae, facetal joints, nerve 
roots and meninges. The most common causes of 
spinal pain in a young adult dog include discospond-
ylitis, cervical instability (cervical spomdylopathy, 
atlanto-axial subluxation), intervertebral disk extru-
sion or protrusion pinching nerve root or meninges, 
trauma (fracture), and occasionally bacterial menin-
gitis and vertebral or meningeal neoplasia.
a neutral lateral cervical radiograph should 
always be considered in any dog presenting with 
cervical pain, before manipulation of the atlantoaxial 
joint is performed due to the possibility of instabil-
ity within this region. Preferably, radiographs should 
be taken with the animal in a conscious state, if such 
instability is suspected. Radiography may also reveal 
evidence of disconspondylitis, i.e. radiopaque irregu-
lar proliferative lesions located at the vertebral end 
plates (sclerosis) with associated lysis or evidence of 
disc disease. In case the initial radiographic evalua-
tion does not reveal any abnormality, then specific 
diagnostic imaging procedures can be performed 
(myelography, magnetic resonance imaging).
Once these procedures have been performed to 
rule out instability, then it is safe to proceed with 
collecting a cerebrospinal fluid sample from the cer-
ebromedullary cistern. Neutrophilic or mixed pleo-
cytosis in the cerebrospinal fluid can be caused by a 
variety of conditions, such as protozoal and bacterial 
diseases. Therefore, in the presence of inflammatory 
cerebrospinal fluid disease, other causes should be 
excluded by appropriate testing, for example cer-
ebrospinal fluid PCR testing for neosporosis. The dif-
ferentiation of steroid-responsive meningitis-arteritis 
from bacterial meningitis is challenging; the latter is 
uncommon in dogs and can be diagnosed by culture 
of cerebrospinal fluid samples and the identification 
of microorganisms in direct observation of smears 
prepared from the sample (Meric et al., 1985; Tipold, 
1995; Radaelli and Platt, 2002). Cerebrospinal fluid 
bacterial culture has a low sensitivity; thus, it may be 
vital to proceed to the more sensitive blood cultures 
(Radaelli and Platt, 2002).
Other potential causes of inflammatory brain 
cerebrospinal fluid total protein concentration can 
also be expected (reference range: <250 mg L-1 for 
cerebellomedullary cistern collection) (Di Terlizzi 
and Platt, 2006; Tipold, 2000). The cerebrospinal 
fluid total protein concentration in the chronic form 
may be within normal limits or slightly elevated 
(Tipold, 2000). Cerebrospinal fluid changes appear 
sensitive to immunosuppressive doses of steroid 
administration and will be suppressed if the patient 
has received treatment prior to cerebrospinal fluid 
sampling, although further investigation would be 
required to evaluate whether any particular cell lines 
are affected preferentially (Lowrie et al., 2008).
Haematological findings may demonstrate evi-
dence of a leucocytosis with left shift (Hayes et al., 
1989). Serum biochemistry results may reveal a mild 
hypoalbuminaemia due to the inflammatory reaction, 
as albumin is a negative acute phase protein (Cerón 
et al., 2005). Hyperglobulinaemia has also been 
reported; increased concentrations of Iga are likely 
responsible for this (Tipold and Jaggy, 1994; Tipold 
et al., 1995).
In both the acute and chronic forms of the dis-
ease, Iga concentrations are increased in blood and 
cerebrospinal fluid. Though the increase in Iga in the 
cerebrospinal fluid is a common feature of many cen-
tral nervous system diseases, the significant increase 
in serum concentrations is more characteristic, as 
in other central nervous system diseases concentra-
tions may be normal or slightly increased (Tipold 
and Jaggy, 1994; Tipold et al., 1995). Therefore, 
Iga measurements can be useful for differentiation 
of steroid-responsive meningitis-arteritis from other 
neurological disorders. This can be especially helpful 
in the chronic form, which is not easily distinguished 
in terms of clinical presentation from other similar 
diseases. Specificity of the test varies from 88% 
(Tipold and Jaggy, 1994) to 100% (Tipold et al., 
1995). as part of the differential diagnosis process, 
one should be aware that increased serum Iga may 
also be present in animals with lymphoma, myeloma 
or histiocytosis (Tipold, 2000).
Evaluation of acute phase proteins can also be 
useful for diagnosing the disease. acute phase pro-
teins, e.g. C-reactive protein, blood concentrations 
are increased, as in other inflammatory diseases, and 
may lead to early diagnosis of steroid-responsive 
meningitis-arteritis (Lowrie et al., 2009).
Finally, computed-tomography imaging may 
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prednisolone protocol (Schatzberg, 2010) which can 
be followed is as below:
 1.5 mg kg-1 bw, per os or intravenously, bid for 3 
weeks,
 1.0 mg kg-1 bw, per os or intravenously, bid for 6 
weeks,
 0.5 mg kg-1 bw, per os or intravenously, bid for 3 
weeks,
 0.5 mg kg-1 bw, per os or intravenously, sid for 3 
weeks,
 0.5 mg kg-1 bw, per os or intravenously, every two 
days indefinitely; the dose may be reduced to 0.25 
mg kg-1 bw, per os or intravenously, every two days 
at a later stage.
Response to corticosteroids is variable and may 
be temporary, altough dogs often show a good initial 
response to steroid monotherapy. a median survival 
time of 36 days (range: 2-1200 days) after corticos-
teroid treatment in 26 dogs with meningoencepha-
lomyelitis of unknown aetiology has been reported 
(Granger et al., 2010). Steroid monotherapy may 
adequately control the clinical signs, but it has been 
proved to be insufficient for some patients. In addi-
tion, long-term, high dose corticosteroid therapy may 
cause side-effects, including polyuria/polydipsia, 
polyphagia, weight gain, hepatotoxicity, gastrointes-
tinal ulceration, pancreatitis and iatrogenic hyper-
adrenocorticism. For the above reasons, it is essential 
either to combine steroids with one or more immu-
nomodulatory drugs or less often to use the latter as 
a monotherapy. Cytosine arabinoside, procarbazine, 
cyclosporine, lomustine, leflunomide and mycophe-
nolate mofetil, all have been reported as additional 
and effective therapies. However, more clinical trials 
are needed to confirm their efficacy in controlling 
meningoencephalomyelitis of unknown aetiology 
(Schatzberg, 2010).
It is also advisable to use gastroprotectants in 
combination with the steroid therapy. Therefore, 
dogs should concurrently receive sucralfate (1-2 g 
per animal, per os, tid), ranitidine (2 mg kg-1 bw, per 
os, bid) or famotidine (0.5-1 mg kg-1 bw, per os, sid) 
(Lowrie, 2011).
Management of steroid responsive meningitis-
arteritis
Initially, immunosuppressive doses of steroids 
disease include granulomatous meningoencephalo-
myelitis and necrotising encephalitis. These diseases 
can be confused with the chronic form of steroid-
responsive meningitis-arteritis, when neurological 
deficits are present. However, these diseases cause 
brain dysfunction in addition to myelopathy, while 
in the chronic form of steroid-responsive meningitis-
arteritis more often spinal syndrome occurs with no 
brain involvement. In such cases with brain involve-
ment, the information from the history (i.e., progress 
from acute steroid-responsive meningitis-arteritis) 
may be helpful in differentiation. advanced imaging 
studies are recommended to evaluate brain involve-
ment in the disease.
Prognosis
Prognosis is guarded to good. In acute form and 
with appropriate treatment, prognosis is excellent. In 
contrast, in the chronic form with symptoms of mye-
litis and/or encephalitis, the prognosis is guarded and 
fatality ranges from 5% to 100% (Tipold and Jaggy, 
1994; Cizinauskas et al., 2000).
THERAPEUTIC APPROACH FOR 
MENINGOENCEPHALOMYELITIS OF 
UNKNOWN AETIOLOGY
Management of granulomatous meningoencepha-
lomyelitis and necrotising encephalitis
The cornerstone of management of granulo-
matous meningoencephalomyelitis and necrotising 
encephalitis is immunosuppressive treatment, main-
ly with corticosteroids. Depending on the sever-
ity of signs and whether or not there is the suspicion 
for infectious diseases, the clinician may initially 
administer anti-inflammatory dosages of steroids 
(prednisolone at 0.5-1.0 mg kg-1 bw, per os or intra-
venously, once daily) and wait for the results of 
serological examination and PCR. If the results do 
not provide evidence for an infectious disease or if 
index of suspicion for meningoencephalomyelitis 
of unknown aetiology is very high from the begin-
ning (e.g., dog of Pug breed with magnetic reso-
nance imaging lesions consistent with necrotising 
meningoencephalitis), then the clinician can start 
the immunosuppressive therapy directly and gradu-
ally reduce the dose to the minimum that adequately 
controls the disease (Schatzberg, 2010). a proposed 
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ebrospinal fluid culture yields no more microorgan-
isms (Friedland and McCracken, 1994).
During treatment, Iga concentrations in blood 
and cerebrospinal fluid remain increased despite 
regression of clinical signs (Tipold, 2000). In addi-
tion to this, measurement of acute phase protein 
concentration in blood is useful for evaluation of the 
response to the treatment. During treatment, almost 
concentrations of all acute phase protein decrease 
significantly compared to their initial values. In con-
trast, acute phase protein concentrations in cerebros-
pinal fluid are less reliable markers for evaluation of 
the response of steroid responsive meningitis-arteritis 
to the treatment (Lowrie et al., 2009).
CONCLUDING REMARKS
Meningoencephalomyelitis of unknown aetiol-
ogy includes diseases of the central nervous sys-
tem, with an immune mediated background and dis-
tinct neuropathological findings. Treatment is based 
on administration of immunosuppressive drugs. In 
addition to prednisolone, immunosuppressive drugs 
appear to have a beneficial effect in management 
of the diseases, improving their overall prognosis. 
In the future, effective treatments will possibly be 
established after elucidation of the pathogenesis of 
these diseases.
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(prednizolone) can be used, these being gradually 
reduced within a period of months to the minimum 
dose that can control the disease. approximately 
50% of dogs with steroid responsive meningitis-
arteritis relapse after discontinuation of treatment 
(Le Couteur, 2009). Furthermore, in dogs not treated 
appropriately, chronic form of the disease develops 
(Tipold, 2000). For this reason, it is important that 
treatment should last at least six months, in order to 
reduce possibility of disease relapse (Le Couteur, 
2009).
another treatment protocol can be based on 
administration of prednisolone (4 mg kg-1 bw, per 
os or intravenously, sid) initially, followed, after 2 
days by a reduction in the dose to 2 mg kg-1 bw for 
one to two weeks, followed by a further reduction 
to 1 mg kg-1 bw for another 2 weeks. at that point 
and then every 4 to 6 weeks, the dog is re-examined 
clinically and an evaluation of cerebrospinal fluid 
and a haematological examination are performed. 
When clinical and laboratory findings are normal, 
the dose can be gradually reduced to half that of the 
preceding regime, until a dose rate of 0.5 mg kg-1 bw 
per os every 48 or 72 hours is attained. Treatment 
is stopped 6 months after clinical and laboratory 
findings are normal. If clinical neurologic examina-
tion reveals abnormalities in the presence of normal 
cerebrospinal fluid examination results, then it would 
be advisable to increase again the dose of prednisolo-
ne or to combine it with another immunomodula-
tory drug (Tipold and Jaggy 1994, Cizinauskas et al. 
2000). a good suggestion would be azathioprine (1.5 
mg kg-1 bw, per os, every 48 hours) which may be 
used in combination with steroids (e.g., alternating 
each drug every other day) (Tipold, 2000).
If the diagnosis is uncertain and there is suspi-
cion of infectious (possibly bacterial) meningitis, 
then an antibiotic which can penetrate the blood-
brain barrier should be administered. Such antibiotics 
are clindamycin (12.5-25 mg kg-1 bw, per os, bid) 
and trimethoprim/sulphonamides combination. The 
use of antibiotics should be stopped when the cer-
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